Medicines Australia’s Continuing Education Program (CEP) is designed to educate medical representatives to a recognised industry standard. Dr Tristan Ling, CEP Academic Lead and Project Manager at the College of Health and Medicine, University of Tasmania talks about the 900 students that come through the program each year.
The CEP is primarily directed at medical representatives working within the prescription medicines industry, but is also recommended to people who may not be currently employed within the industry but would like to pursue a career as a medical representative. It is also available to personnel working for organisations interacting with the pharmaceutical industry.
Medicines Australia CEO Elizabeth de Somer talks about how the CEP program provides the information needed by medical representatives, that talk to health care professionals, talk with accuracy, balance and in an evidence based manner about their products.
Australian Health Journal spoke with recent CEP graduates Samantha Wicks, Christopher Lems and Megan-Anne Jefferys on their experiences in the program and how it positively impacted their confidence and knowledge of the industry.
The CEP is currently offered online through the University of Tasmania’s Unit for Medication Outcomes Research and Education (UMORE), which is housed in the University’s Pharmacy Division.
You Might also like
-
LIVED EXPERIENCE: severe aortic valve stenosis (aortic stenosis)
A Batemans Bay grandfather who dismissed months of breathlessness and fatigue as “just getting older” is now preparing to travel to Singapore to meet the technicians who hand-stitched the heart valve that helped save his life.
In April 2026, retired logistics courier, Geoff Lewis, 75, collapsed in front of his daughter and grandchildren while on holiday in Thailand, after months of symptoms he had ignored. The collapse would lead to a diagnosis of severe aortic stenosis and urgent treatment back home.
-
ICTD: Why negative results in clinical trials matter
To mark International Clinical Trials Day 2026, Australian Health Journal commences a 4 part special series leaving up to 20th May. Through conversations with leading researchers, clinicians and trial organisations, the series highlights achievements in the year that was for clinical trials.
Negative results in a clinical trial can be extremely valuable — both scientifically and ethically. A “negative result” usually means the treatment being tested did not work better than the standard treatment, placebo, or expected outcome.Negative results in a clinical trial can be extremely valuable — both scientifically and ethically. A “negative result” usually means the treatment being tested did not work better than the standard treatment, placebo, or expected outcome.
-
Role of the Chief Nursing Officer
Professor Alison McMillan PSM spoke with Australian Health Journal about the role of Chief Nursing and Midwifery Officer at the Australian Government Department of Health and Aged Care.
Alison was appointed as our Chief Nursing and Midwifery Officer in November 2019.
In June 2021 Alison was awarded a Public Service Medal for outstanding public service to driving the Government’s national health response priorities during the COVID-19 pandemic, particularly to infection prevention measures.